↓ Skip to main content

Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?

Overview of attention for article published in Journal of Translational Medicine, June 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
17 news outlets
twitter
38 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?
Published in
Journal of Translational Medicine, June 2013
DOI 10.1186/1479-5876-11-139
Pubmed ID
Authors

Thomas E Ichim, Timothy Warbington, Octav Cristea, Joseph L Chin, Amit N Patel

Abstract

While PDE5 inhibitors have revolutionized treatment of ED, approximately 30% of patients are non-responsive. A significant cause of this is vascular and smooth muscle dysfunction, as well as nerve atrophy. Autologous administration of bone marrow mononuclear cells (BMMC) has been performed in over 2000 cardiac patients without adverse effects, for stimulation of angiogenesis/regeneration. Despite its ease of access, and dependence on effective vasculature for function, comparatively little has been perform in terms of BMMC therapy for ED. Here we outline the rationale for use of autologous BMMC in patients with ED, as well as provide early safety data on the first use of this procedure clinically.

X Demographics

X Demographics

The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 15%
Other 5 10%
Student > Ph. D. Student 4 8%
Student > Master 3 6%
Professor > Associate Professor 3 6%
Other 4 8%
Unknown 22 46%
Readers by discipline Count As %
Medicine and Dentistry 13 27%
Engineering 3 6%
Nursing and Health Professions 2 4%
Psychology 2 4%
Sports and Recreations 2 4%
Other 4 8%
Unknown 22 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 149. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2023.
All research outputs
#273,649
of 25,235,161 outputs
Outputs from Journal of Translational Medicine
#69
of 4,594 outputs
Outputs of similar age
#1,726
of 203,739 outputs
Outputs of similar age from Journal of Translational Medicine
#2
of 42 outputs
Altmetric has tracked 25,235,161 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,594 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,739 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.